# Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

> **NCT04078568** · PHASE3 · COMPLETED · sponsor: **Children's Hospital of Fudan University** · enrollment: 3208 (actual)

## Conditions studied

- Kawasaki Disease

## Interventions

- **DRUG:** IVIG
- **DRUG:** Aspirin
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT04078568
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-15
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-11-06
- **Target enrollment:** 3208 (ACTUAL)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078568, "Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04078568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*